1. Home
  2. BMRN vs MOH Comparison

BMRN vs MOH Comparison

Compare BMRN & MOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • MOH
  • Stock Information
  • Founded
  • BMRN 1996
  • MOH 1980
  • Country
  • BMRN United States
  • MOH United States
  • Employees
  • BMRN N/A
  • MOH N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • MOH Medical Specialities
  • Sector
  • BMRN Health Care
  • MOH Health Care
  • Exchange
  • BMRN Nasdaq
  • MOH Nasdaq
  • Market Cap
  • BMRN 11.1B
  • MOH 9.8B
  • IPO Year
  • BMRN 1999
  • MOH 2003
  • Fundamental
  • Price
  • BMRN $54.65
  • MOH $203.93
  • Analyst Decision
  • BMRN Buy
  • MOH Hold
  • Analyst Count
  • BMRN 20
  • MOH 12
  • Target Price
  • BMRN $92.21
  • MOH $228.18
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • MOH 1.0M
  • Earning Date
  • BMRN 10-28-2025
  • MOH 10-22-2025
  • Dividend Yield
  • BMRN N/A
  • MOH N/A
  • EPS Growth
  • BMRN 154.69
  • MOH 11.17
  • EPS
  • BMRN 3.40
  • MOH 20.27
  • Revenue
  • BMRN $3,063,608,000.00
  • MOH $41,703,000,000.00
  • Revenue This Year
  • BMRN $13.35
  • MOH $14.57
  • Revenue Next Year
  • BMRN $9.18
  • MOH $6.77
  • P/E Ratio
  • BMRN $16.09
  • MOH $10.03
  • Revenue Growth
  • BMRN 18.36
  • MOH 15.57
  • 52 Week Low
  • BMRN $52.48
  • MOH $151.95
  • 52 Week High
  • BMRN $73.51
  • MOH $359.97
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 47.87
  • MOH 67.64
  • Support Level
  • BMRN $53.19
  • MOH $190.37
  • Resistance Level
  • BMRN $54.50
  • MOH $195.56
  • Average True Range (ATR)
  • BMRN 1.20
  • MOH 5.75
  • MACD
  • BMRN 0.29
  • MOH 1.97
  • Stochastic Oscillator
  • BMRN 62.43
  • MOH 91.44

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About MOH Molina Healthcare Inc

Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

Share on Social Networks: